OQL 071
Alternative Names: OQL-071Latest Information Update: 11 Apr 2022
Price :
$50 *
At a glance
- Originator OnQuality Pharmaceuticals
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Alopecia
Most Recent Events
- 07 Apr 2022 Early research in Alopecia in USA (unspecified route) prior to April 2022 (OnQuality Pharmaceutical's pipeline, April 2022)